Nexentis Technologies Inc.: Item 5.02 filing

NXTS · Nasdaq · Pharmaceutical Preparations · <br>Emerging growth company · NY · Form 8-K filed 2026-10-19

No executive or director changes disclosed; Item 5.02 incorporates Item 3.02 by reference without providing specific personnel details.

Events in this filing

0 events: .

Names, stated reasons, successor status, compensation terms and the evidence quotes are shown to subscribers. See plans

Item 5.02 as filed

Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
The
disclosure set forth in clauses (ii), (iii) and (iv) of Item
3.02 above is incorporated herein by reference.

Source filing on EDGAR →